Covered recipient · General Payments record
JOCELYN F HENDRICKS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2024
$853.08
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $220.90 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $100.45 | 4 |
| Janssen Pharmaceuticals, Inc | $40.00 | 2 |
| ABBVIE INC. | $30.10 | 1 |
| E.R. Squibb & Sons, L.L.C. | $27.61 | 1 |
| Novo Nordisk AS | $22.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.10 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103904426 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.58 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104752910 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.35 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105847895 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.47 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104443371 | CMS |
| AstraZeneca Pharmaceuticals LP | $34.05 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105324175 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.61 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101298264 | CMS |
| Janssen Pharmaceuticals, Inc | $18.49 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077916951 | CMS |
| Janssen Pharmaceuticals, Inc | $21.51 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077917325 | CMS |
| Novo Nordisk Inc | $22.74 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617398 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.